Literature DB >> 9704693

Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect.

N Nagaya1, T Nishikimi, M Uematsu, S Kyotani, T Satoh, N Nakanishi, H Matsuo, K Kangawa.   

Abstract

UNLABELLED: BACKGROUND This study was designed to investigate plasma levels of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) in patients with atrial septal defect (ASD), whose right ventricular loading patterns vary from simple volume overloading to both volume and pressure overloading. METHODS AND
RESULTS: Plasma ANP and BNP in the pulmonary artery were measured in 31 adult patients with ASD and 11 control subjects. On the basis of the presence of pulmonary hypertension (PH, mean pulmonary arterial pressure >20 mm Hg), patients with ASD were divided into two groups, patients without PH (group 1, n = 21) and those with PH (group 2, n = 10). Cardiac catheterization was performed to measure mean pulmonary arterial pressure and pulmonary blood flow. Plasma ANP was significantly higher in both group 1 and group 2 than in the control group. Plasma BNP and BNP to ANP (BNP/ANP) ratio were significantly higher in group 2 than in the control group, although they were not significantly elevated in group 1. Plasma ANP positively correlated with the degree of pulmonary blood flow (r = 0.54, p < 0.01), whereas plasma BNP positively correlated with the magnitude of mean pulmonary arterial pressure (r= 0.73, p < 0.001). BNP/ANP >1 was a powerful marker for the presence of PH (sensitivity 90%, specificity 90%).
CONCLUSIONS: Plasma ANP levels were elevated in adult patients with ASD regardless of PH. In contrast, plasma BNP levels were elevated in proportion to the severity of PH complicating ASD. Thus BNP and ANP may represent differing aspects of cardiac response to right ventricular overload in patients with ASD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9704693     DOI: 10.1053/hj.1998.v136.89729

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  14 in total

1.  NT-proBNP correlated with strain and strain rate imaging of the right ventricle before and after transcatheter closure of atrial septal defects.

Authors:  Raghda Ghonimy Elsheikh; Mohamed Hegab; Andras Szatmari
Journal:  J Saudi Heart Assoc       Date:  2012-10-13

Review 2.  Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology.

Authors:  Werner Budts; Jolien Roos-Hesselink; Tanja Rädle-Hurst; Andreas Eicken; Theresa A McDonagh; Ekaterini Lambrinou; Maria G Crespo-Leiro; Fiona Walker; Alexandra A Frogoudaki
Journal:  Eur Heart J       Date:  2016-01-18       Impact factor: 29.983

3.  Neurohormonal activation late after cavopulmonary connection.

Authors:  V E Hjortdal; E V Stenbøg; H B Ravn; K Emmertsen; K T Jensen; E B Pedersen; K H Olsen; O K Hansen; K E Sørensen
Journal:  Heart       Date:  2000-04       Impact factor: 5.994

Review 4.  Current Role of Blood and Urine Biomarkers in the Clinical Care of Adults with Congenital Heart Disease.

Authors:  Saurabh Rajpal; Laith Alshawabkeh; Alexander R Opotowsky
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

5.  Atrial septal defect closure and migraine with aura: is there a correlation?

Authors:  Paola Castellini; Giorgio Lambru; Gian Camillo Manzoni; Paola Torelli
Journal:  Neurol Sci       Date:  2009-05-20       Impact factor: 3.307

6.  Atrial natriuretic peptide and three-dimensional echocardiography after transcatheter closure of atrial septal defect.

Authors:  Jingdong Ding; Genshan Ma; Yaoyao Huang; Xiaoli Zhang; Biao Liu; Fengxiang Lu
Journal:  Cardiovasc Ultrasound       Date:  2008-07-07       Impact factor: 2.062

7.  Changes in serum natriuretic peptide levels after percutaneous closure of small to moderate ventricular septal defects.

Authors:  Yuksel Kaya; Ramazan Akdemir; Huseyin Gunduz; Sani Murat; Orhan Bulut; Ibrahim Kocayigit; M Bulent Vatan; M Akif Cakar; Ekrem Yeter; Harun Kilic; Mustafa Tarik Agac; Zeydin Acar
Journal:  ScientificWorldJournal       Date:  2012-04-26

8.  Updating clinical endpoint definitions.

Authors:  Paul M Hassoun; Sylvia Nikkho; Erika B Rosenzweig; Gail Moreschi; John Lawrence; John Teeter; Christian Meier; Ardeshir H Ghofrani; Omar Minai; Paula Rinaldi; Evangelos Michelakis; Ronald J Oudiz
Journal:  Pulm Circ       Date:  2013-01       Impact factor: 3.017

9.  Correlation of plasma B-type natriuretic peptide with shunt severity in patients with atrial or ventricular septal defect.

Authors:  H Ozhan; S Albayrak; H Uzun; S Ordu; A Kaya; M Yazici
Journal:  Pediatr Cardiol       Date:  2007-05-25       Impact factor: 1.838

10.  Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Biomarkers in pulmonary arterial hypertension.

Authors:  Omar A Minai
Journal:  Ann Thorac Med       Date:  2014-07       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.